what are the Recommendations for Renin-Angiotensin System Inhibition With ACE Inhibitor or ARB or ARNI?
The clinical strategy of inhibition of the renin-angiotensin system with ACE inhibitors (Level of Evidence: A),128?133 OR ARBs (Level of Evidence: A),134?137 OR ARNI (Level of Evidence: B-R)138 in conjunction with evidence- based beta blockers,9,139,140 and aldosterone antagonists in selected patients,141,142 is recommended for patients with chronic HFrEF to reduce morbidity and mortality.